English | 繁體

Search in the results

UM

Browse/Search Results:  1-10 of 57 Help

Selected(0)Clear Items/Page:    Sort:
Microfluidic detection using G-quadruplex DNA-based biosensors Journal article
Wu, Jia, Li, Yujie, Wang, Lijun, Nao, Sang Cuo, Shiu-Hin Chan, Daniel, Wong, Chun Yuen, Yang, Guanjun, Wang, Wanhe, Leung, Chung Hang. Microfluidic detection using G-quadruplex DNA-based biosensors[J]. TrAC - Trends in Analytical Chemistry, 2025, 184, 118121.
Authors:  Wu, Jia;  Li, Yujie;  Wang, Lijun;  Nao, Sang Cuo;  Shiu-Hin Chan, Daniel; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:11.8/12.7 | Submit date：2025/01/22
G-quadruplex  Microfluidics  Biosensors  Ligand  Biomarker  Drug Screening  
A NIR iridium(III) complex-based luminescence probe for imaging mitochondria pyruvate dehydrogenase kinase 1 in triple-negative breast cancer cells Journal article
Jing, Shaozhen, Song, Ying Qi, Liu, Jingqi, Zhao, Chen, Wang, Ling, Chan, Daniel Shiu Hin, Wong, Chun Yuen, Lee, Simon Ming Yuen, Wang, Jing, Leung, Chung Hang, Wang, Wanhe. A NIR iridium(III) complex-based luminescence probe for imaging mitochondria pyruvate dehydrogenase kinase 1 in triple-negative breast cancer cells[J]. Sensors and Actuators B: Chemical, 2024, 418, 136265.
Authors:  Jing, Shaozhen;  Song, Ying Qi;  Liu, Jingqi;  Zhao, Chen;  Wang, Ling; et al.
Favorite | TC[WOS]:0 TC[Scopus]:1  IF:8.0/7.0 | Submit date：2024/08/05
Breast Cancer  Dichloroacetic Acid (Dca)  Iridium(Iii) Complex  Mitochondrial Targeting  Nir Imaging  Pyruvate Dehydrogenase Kinase 1 (Pdk1)  
Tailoring obeticholic acid activity by iridium(III) complex conjugation to develop a farnesoid X receptor probe Journal article
Niu, Dou, Wu, Xiaolei, Zhang, Yuxin, Wang, Xueliang, Shiu-Hin Chan, Daniel, Jing, Shaozhen, Wong, Chun Yuen, Wang, Wanhe, Leung, Chung Hang. Tailoring obeticholic acid activity by iridium(III) complex conjugation to develop a farnesoid X receptor probe[J]. Journal of Advanced Research, 2024.
Authors:  Niu, Dou;  Wu, Xiaolei;  Zhang, Yuxin;  Wang, Xueliang;  Shiu-Hin Chan, Daniel; et al.
Favorite | TC[Scopus]:0  IF:11.4/11.0 | Submit date：2024/12/05
Iridium Complex  Fxr  Nuclear Receptor  Tailoring Activity  Imaging Probe  
Probing the AFF4–CCNT1 protein–protein interaction using a metal–organic conjugate for treating triple-negative breast cancer Journal article
Song, Ying Qi, Xu, Yiwen, Yang, Li Jun, Wang, Ling, Jing, Shaozhen, Yang, Guan Jun, Shiu-Hin Chan, Daniel, Wong, Chun Yuen, Wang, Wanhe, Kam Wai Wong, Vincent, Leung, Chung Hang. Probing the AFF4–CCNT1 protein–protein interaction using a metal–organic conjugate for treating triple-negative breast cancer[J]. Chemical Engineering Journal, 2024, 496, 153685.
Authors:  Song, Ying Qi;  Xu, Yiwen;  Yang, Li Jun;  Wang, Ling;  Jing, Shaozhen; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:13.3/13.2 | Submit date：2024/08/05
Aff4  Ccnt1  Metal–organic Conjugate  Protein–protein Interaction  Triple-negative Breast Cancer  
Probing the AFF4-CCNT1 protein-protein interaction using a metal-organic conjugate for treating triple-negative breast cancer Journal article
Ying-Qi Song, Yiwen Xu, Li-Jun Yang, Ling Wang, Zhao Zhen Jing, Guan-Jun Yang, Daniel Shiu-Hin Chan, Chun-Yuen Wong, Wanhe Wang, Vincent Kam Wai Wong, Chung-Hang Leung. Probing the AFF4-CCNT1 protein-protein interaction using a metal-organic conjugate for treating triple-negative breast cancer[J]. Chemical Engineering Journal, 2024, 496, 153685.
Authors:  Ying-Qi Song;  Yiwen Xu;  Li-Jun Yang;  Ling Wang;  Zhao Zhen Jing; et al.
Favorite |   IF:13.3/13.2 | Submit date：2024/08/30
PiRNA-4447944 promotes castration-resistant growth and metastasis of prostate cancer by inhibiting NEFH expression through forming the piRNA-4447944-PIWIL2-NEFH complex Journal article
Peng, Qiang, Chen, Yu, Xie, Tingting, Pu, Dandan, Ho, Vincy Wing Sze, Sun, Jingkai, Liu, Kang, Chan, Ronald Cheong Kin, Ding, Xiaofan, Teoh, Jeremy Yuen Chun, Wang, Xin, Chiu, Peter Ka Fung, Ng, Chi Fai. PiRNA-4447944 promotes castration-resistant growth and metastasis of prostate cancer by inhibiting NEFH expression through forming the piRNA-4447944-PIWIL2-NEFH complex[J]. International journal of biological sciences, 2024, 20(9), 3638-3655.
Authors:  Peng, Qiang;  Chen, Yu;  Xie, Tingting;  Pu, Dandan;  Ho, Vincy Wing Sze; et al.
Favorite | TC[WOS]:1 TC[Scopus]:1  IF:8.2/8.3 | Submit date：2024/08/05
Castration Resistance  Nefh  Pir-4447944  Piwi-interacting Rnas  Prostate Cancer  
Luminescent iridium(iii)-peptide bioconjugates for bioanalytical and biomedical applications Review article
2024
Authors:  Jing, Shaozhen;  Wu, Xiaolei;  Chan, Daniel Shiu Hin;  Nao, Sang Cuo;  Du, Jianxiong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:3  IF:6.1/5.9 | Submit date：2024/06/05
Luminescent iridium(iii)-peptide bioconjugates for bioanalytical and biomedical applications Journal article
Jing, Shaozhen, Wu, Xiaolei, Chan, Daniel Shiu Hin, Nao, Sang Cuo, Du, Jianxiong, Wong, Chun Yuen, Wang, Jing, Leung, Chung Hang, Wang, Wanhe. Luminescent iridium(iii)-peptide bioconjugates for bioanalytical and biomedical applications[J]. Inorganic Chemistry Frontiers, 2024, 11(12), 3400-3417.
Authors:  Jing, Shaozhen;  Wu, Xiaolei;  Chan, Daniel Shiu Hin;  Nao, Sang Cuo;  Du, Jianxiong; et al.
Favorite | TC[WOS]:0 TC[Scopus]:3  IF:6.1/5.9 | Submit date：2024/09/03
Luminescent iridium(III)-peptide bioconjugates for bioanalytical and biomedical applications Journal article
S Jing, X Wu, DSH Chan, Sang-Cuo Nao, J Du, Chun-Yuen Wong, Jing Wang, Chung-Hang Leung, Wanhe Wang. Luminescent iridium(III)-peptide bioconjugates for bioanalytical and biomedical applications[J]. Inorganic Chemistry Frontiers, 2024.
Authors:  S Jing;  X Wu;  DSH Chan;  Sang-Cuo Nao;  J Du; et al.
Favorite |   IF:6.1/5.9 | Submit date：2024/08/30
Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform Journal article
Nao, Sang Cuo, Huang, Le Sheng, Shiu-Hin Chan, Daniel, Wang, Xueliang, Li, Guo Dong, Wu, Jia, Wong, Chun Yuen, Wang, Wanhe, Leung, Chung Hang. Repurposing sodium stibogluconate as an uracil DNA glycosylase inhibitor against prostate cancer using a time-resolved oligonucleotide-based drug screening platform[J]. Bioorganic Chemistry, 2024, 144, 107176.
Authors:  Nao, Sang Cuo;  Huang, Le Sheng;  Shiu-Hin Chan, Daniel;  Wang, Xueliang;  Li, Guo Dong; et al.
Favorite | TC[WOS]:2 TC[Scopus]:2  IF:4.5/4.7 | Submit date：2024/04/02
Drug Repurposing  Drug Screening  Iridium(Iii) Complex  Time-resolved Emission  Uracil-dna Glycosylase